Hand holding the newspaper resting on a table with a cup of coffee


The Latest News From the Ivy Center

The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics. 

Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs. 

To contact the media relation team, call Jennifer Keeler at 602-670-4400 or email: [email protected]

Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog. 

Taxonomy Icon
Ivy Brain Tumor Center Announces Promising Data for Niraparib in Phase 0/2 Glioblastoma Clinical Trial  
  • November 17, 2023
The Ivy Brain Tumor Center at Barrow Neurological Institute announces promising results from a collaborative Phase 0/2 trial of niraparib, supported by GSK, in patients with newly diagnosed glioblastoma with unmethylated MGMT.
Taxonomy Icon
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
  • November 6, 2023
The Ivy Brain Tumor Center announced the first patient has been treated in a novel Phase 0/1 clinical trial of BDTX-1535, an experimental drug targeting oncogenic EGFR (epidermal growth factor receptor) mutations in patients with recurrent high-grade glioma.
Taxonomy Icon
Center focused on finding cure for glioblastoma reveals AstraZeneca drug may be a success
  • October 20, 2023
  • Source: OutsourcingPharma
Outsourcing Pharma recently spotlighted the Ivy Center's groundbreaking clinical trial on AZD1390 for recurrent glioblastoma patients. The Ivy Center unveiled promising initial results, indicating that AZD1390 may act as a potent radio-sensitizer in human glioblastoma cases. This discovery marks the first instance where AZD1390's potential efficacy in enhancing radiation therapy for glioblastoma has been documented in humans. These results highlight the Ivy Center's commitment to pioneering advancements in glioblastoma treatment.
Taxonomy Icon
Ivy Brain Tumor Center Announces Results of Phase 0/1 Study in Recurrent Glioblastoma Patients at the European Society for Medical Oncology (ESMO) 2023 Congress
  • October 18, 2023
The Ivy Brain Tumor Center announced initial results from a Phase 0/1 clinical trial of the Ataxia telangiectasia mutated (ATM) kinase inhibitor AZD1390 in recurrent glioblastoma in combination with radiation therapy.
Taxonomy Icon
John McCain’s son says fight to cure glioblastoma continues 5 years after senator’s death
  • August 25, 2023
  • Source: 12News
August 25th marked five years since our nation lost Senator John McCain to a deadly glioblastoma brain tumor. The Ivy Brain Tumor Center honors Senator McCain and all those affected by this devastating disease by remaining committed to our mission to find a cure for patients with brain tumors. Andy McCain, son of John McCain and avid supporter of the Ivy Center, appeared on 12News to talk about his father and how the family remembers him.
Taxonomy Icon
Phoenix brain tumor center aims to cure same cancer that took Sen. John McCain’s life
  • August 25, 2023
  • Source: AZ Family
In memory of Senator John McCain, Andy McCain, a board member at the Ivy Brain Tumor Center, carries on the fight against brain cancer. Led by Dr. Nader Sanai, the center pioneers innovative clinical trials, inspired by survivors like Jenn Ortiz. AZ Family highlights the efforts of the Ivy Center's efforts to find a cure the progress that has been made in the landscape of brain cancer treatment.
Taxonomy Icon
How has brain cancer treatment, research advanced since Senator McCain’s death?
  • August 25, 2023
  • Source: ABC15 Arizona
Discover five years of transformative progress against glioblastoma through ABC15's illuminating coverage of the Ivy Brain Tumor Center. They delve into innovative treatments, patient stories like Heather Knies', and the visionary leadership of Director Dr. Nadar Sanai. Read the full coverage here.
Taxonomy Icon
Sanai Spotlights Meningioma Symptoms, Treatment Options, and Research Needs
  • August 10, 2023
  • Source: OncLive
OncLive On Air has a discussion with Dr. Nader Sanai, director of the Ivy Brain Tumor Center. Delve into intricate insights about meningiomas, including prevalence, malignant grading, common symptoms, and innovative treatment modalities for high-grade cases.
Taxonomy Icon
Nurses on the Front Lines Are Helping Patients Navigate Brain Tumor Cancer Care
  • August 9, 2023
  • Source: Oncology Nursing News
Oncology Nursing News highlights Jacki Garcia, RN, BSN, CNRN, and Kristen Hendrickson, BA, RN, and their roles within Phase 0 trials and impact on personalized treatments for brain tumor patients. Join them as they explore the invaluable work of the Ivy Center, providing hope and potential treatment options to those in need.
Taxonomy Icon
‘It’s Not Taking Me’: Valley Mom Fighting Glioblastoma, Doctors Fight For Better Prognoses For Patients
  • July 19, 2023
  • Source: 12 News
In honor of Glioblastoma Awareness Day, Ivy Center patient, Jenn Ortiz, joins 12 News with Dr. Shwetal Mehta to discuss the importance of raising awareness and funds for this devastating disease.